Results 91 to 100 of about 1,511 (180)

[Post-exposure prophylaxis against Ebola virus: arguments for expanding the role of monoclonal antibodies in a context of limited access]. [PDF]

Med Trop Sante Int
Potet J, Adjaho I, Dierberg K, Sprecher A, Coulborn RM.   +4 more
europepmc   +1 more source

Nuvaxovid, un nouveau vaccin anti-Sars-CoV-2. [PDF]

Rev Francoph Lab, 2022
Manus JM.
europepmc   +1 more source

[Clinical aspects of dengue fever in the Savanna region of Togo in 2023]. [PDF]

Med Trop Sante Int
Bawe LD, Kotosso A, Kpegba KA, Hilim M, Kozon D, Abaltou B, Patassi AA, Watéba MI.   +7 more
europepmc   +1 more source

[Risk of emergence of mosquito-borne arboviral diseases in Morocco: literature review]. [PDF]

Med Trop Sante Int
Jdiaa S, Hazyoun H, Louah MA, Himmi O.
europepmc   +1 more source

Syndrome de fuite capillaire systémique après l’administration du vaccin ChAdOx1 nCOV-19 (Oxford–AstraZeneca). [PDF]

CMAJ, 2021
Robichaud J, Côté C, Côté F.
europepmc   +1 more source

Les sénateurs étudient les effets secondaires des vaccins contre la Covid-19. [PDF]

Rev Francoph Lab, 2022
Manus JM.
europepmc   +1 more source

Zoonotic cutaneous leishmaniasis caused by Leishmania major: Do humans play a role in amplifying transmission? [PDF]

Parasite
Aoun K, Maatallah F, Bouratbine A.
europepmc   +1 more source

Le vaccin AstraZeneca-Oxford sur le bureau de l’EMA. [PDF]

Rev Francoph Lab, 2021
Manus JM.
europepmc   +1 more source

Perforations traumatiques du tympan. [PDF]

CMAJ
Harvie M, Roy CF, Gurberg J.
europepmc   +1 more source

[COVID-19 vaccination in patients suffering from respiratory diseases. Update of 25th June 2021]. [PDF]

Rev Mal Respir, 2021
Blanchard E, Ozier A, Janssen C, Wyplosz B, Andrejak C.   +4 more
europepmc   +1 more source